Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-03 00:08:25 - browse：9153

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma. — This immunofluorescence image shows T cells (in green and yellow) in the microenvironment of a head and neck squamous cell carcinoma. Allen Lab/NCI/NIH

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim analysis of an ongoing mid-stage clinical trial.

The new efficacy results, derived from a larger number of patients, look similar to an initial disclosure made last week that triggered a 36% increase in Merus’ stock price.

But the Dutch drugmaker on Tuesday withheld additional information from the study related to the safety and durability of petosemtamab’s tumor responses, pending presentation at the annual meeting of the American Society of Clinical Oncology on June 3.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Celiac disease study examines precisely how gluten triggers injury

WSS

The new HIV moral panic

Grail faces three suits alleging harassment, retaliation

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Intarcia’s device

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

CDC advisers recommend seasonal use of Pfizer RSV shot

entertainment

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

Argenx drug significantly slows progression of nerve disorder

Drug repurposing or repositioning? The language matters

Grail faces three suits alleging harassment, retaliation

Bright Health sells Medicare Advantage business to Molina

Biotech stock slump in 2023: awaiting the turnaround

Medical leaders decry Supreme Court decision on affirmative action

Who gets to use the title 'doctor'?

How one medical school became remarkably diverse

Emergency workers more likely to restrain Black patients: study

hotspot

Senate HELP committee spars over health care workforce policies

Thermo Fisher plant for manufacturing gene therapies to expand

Congress likely to miss an opportunity to fix drug shortages issue

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Experts study whether long Covid risk adds up with each reinfection

Congress: Eradicate hepatitis C and reduce the deficit

hotspot

leisure time

focus

leisure time